angiotensin ii has been researched along with sb 225002 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, HJ; Chen, C; Guo, SB; Han, X; Li, HH; Li, PB; Liu, Y; Teng, F; Xia, YL; Yan, X; Yang, J; Zhang, YL | 1 |
| Bai, J; Ge, YS; Han, X; Li, HH; Lin, QY; Qu, WK; Wang, S; Zhang, PF; Zhang, YL; Zhao, Q | 1 |
2 other study(ies) available for angiotensin ii and sb 225002
| Article | Year |
|---|---|
Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Blood Pressure; Chemokine CXCL1; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Phenylurea Compounds; Receptors, Interleukin-8B; Superoxides | 2020 |
CXCL1-CXCR2 signalling mediates hypertensive retinopathy by inducing macrophage infiltration.
Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Chemokine CXCL1; Cytokines; Hypertensive Retinopathy; Immunoglobulin G; Interleukin-6; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylurea Compounds; Receptors, Interleukin-8B; RNA, Messenger; Superoxides; Tumor Necrosis Factor-alpha | 2022 |